In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.
about
T-cell receptor gene therapy--ready to go viral?How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferNovel serial positive enrichment technology enables clinical multiparameter cell sortingAll-in-one processing of heterogeneous human cell grafts for gene and cell therapy.Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15Construction and evaluation of a novel humanized HER2-specific chimeric receptorTargeted immunotherapy of cancer with CAR T cells: achievements and challenges.Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T-cell subsets exposed to IL-2 versus IL-7/15Human cell-based artificial antigen-presenting cells for cancer immunotherapy.Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.In vitro-activated tumor-specific T lymphocytes prolong the survival of patients with advanced gastric cancer: a retrospective cohort studyA cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.Chimeric antigen receptors in cancer immuno-gene therapy: current status and future directions.Exploiting cytokines in adoptive T-cell therapy of cancer.Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinomaAntileukemia multifunctionality of CD4(+) T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer.The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiespH-Responsive Micelle-Based Cytoplasmic Delivery System for Induction of Cellular Immunity.Antitumor effects and persistence of a novel HER2 CAR T cells directed to gastric cancer in preclinical models.Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.Engineered T lymphocytes eliminate lung metastases in models of pancreatic cancer.
P2860
Q28081611-23694D8C-21F5-4D47-BAD0-44F0C8403EC9Q28727481-E23BFC45-B5A4-4CCB-9E58-58B050C24093Q28730418-489EE6D1-D3D1-418B-8B75-FE90A69CCD1FQ30387995-162B914E-00C5-4BF7-8A5D-8CC2EA523C32Q33749635-1A799BEE-457E-4369-A956-D98E175AE042Q33892746-57393A5D-E53E-4928-B148-F0CE9C445E69Q34270375-BAA127F0-6A22-448C-AF9F-528E8039284DQ34381488-94DF1AA1-018B-4CE6-86BB-6AE5402B4D38Q34391263-F5E20B7B-406E-47B2-8DD6-01C25A9989AFQ35151883-08D69DBC-359C-4E09-A005-B793E6422A1AQ36871188-1B731B18-18F2-47F2-A781-CA9AB5A26B57Q37042451-94DA3FAD-2E8E-4EAA-8B0F-7BBDD1EC9AD5Q37362636-79DC39B6-A464-4013-BE1A-A8AA3341E9C4Q37952805-AA926319-FB11-468F-8BE9-5761839FA7ACQ38525044-9E1118CB-5FB1-4785-887C-9DCD02EFF941Q39924228-FE6EBCC2-FC1D-4495-B2AB-F77F6BE634B7Q41143349-B27F61E0-1904-440C-B113-59A419D3C24BQ41442041-D6430F35-144A-4EDB-871F-CA2BC2DB0239Q47203536-C004C6A3-3AA1-4CF2-9CE7-0298655BA24FQ49477144-5EF4CEE4-25EA-4C20-96C5-B7A239F9A766Q50035377-0E0C5A56-2B2E-40DA-B4E4-C5B1AD1953F4Q50925934-0A9D59EF-3DC9-42C4-8FBC-02780A1157A6Q52641577-5C86F4BA-D767-4E76-9497-34D430D4F7E0
P2860
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@ast
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@en
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@nl
type
label
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@ast
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@en
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@nl
prefLabel
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@ast
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@en
In vitro generated anti-tumor ...... ivo antigen-experienced cells.
@nl
P2093
P2860
P1476
In vitro generated anti-tumor ...... vivo antigen-experienced cells
@en
P2093
Luca Gattinoni
Richard A Morgan
Shicheng Yang
Steven A Rosenberg
P2860
P2888
P304
P356
10.1007/S00262-011-0977-7
P577
2011-02-09T00:00:00Z
P5875
P6179
1050493955